Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

[Plasmodium resistance, a brake on its eradication].

Paloque L, Augereau JM, Benoit-Vical F.

Rev Prat. 2018 Sep;68(7):703-706. French. No abstract available.

PMID:
30869314
2.

Small Molecules: The Past or the Future in Drug Innovation?

Robert A, Benoit-Vical F, Liu Y, Meunier B.

Met Ions Life Sci. 2019 Jan 14;19. pii: /books/9783110527872/9783110527872-008/9783110527872-008.xml. doi: 10.1515/9783110527872-008. Review.

PMID:
30855103
3.

Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.

Ouji M, Augereau JM, Paloque L, Benoit-Vical F.

Parasite. 2018;25:24. doi: 10.1051/parasite/2018021. Epub 2018 Apr 20. Review.

4.

Multiple Phenotypic and Genotypic Artemisinin Sensitivity Evaluation of Malian Plasmodium falciparum Isolates.

Niaré K, Paloque L, Ménard S, Tor P, Ramadani AP, Augereau JM, Dara A, Berry A, Benoit-Vical F, Doumbo OK.

Am J Trop Med Hyg. 2018 Apr;98(4):1123-1131. doi: 10.4269/ajtmh.17-0798. Epub 2018 Feb 8.

5.

Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism.

Paloque L, Witkowski B, Lelièvre J, Ouji M, Ben Haddou T, Ariey F, Robert A, Augereau JM, Ménard D, Meunier B, Benoit-Vical F.

J Antimicrob Chemother. 2018 Feb 1;73(2):395-403. doi: 10.1093/jac/dkx412.

PMID:
29177421
6.

Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.

Keita Alassane S, Nicolau-Travers ML, Menard S, Andreoletti O, Cambus JP, Gaudre N, Wlodarczyk M, Blanchard N, Berry A, Abbes S, Colongo D, Faye B, Augereau JM, Lacroux C, Iriart X, Benoit-Vical F.

PLoS One. 2017 Jul 24;12(7):e0181300. doi: 10.1371/journal.pone.0181300. eCollection 2017.

7.

Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.

Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP.

PLoS One. 2017 Jun 8;12(6):e0179142. doi: 10.1371/journal.pone.0179142. eCollection 2017.

8.

Antiplasmodial activities of gold(I) complexes involving functionalized N-heterocyclic carbenes.

Hemmert C, Ramadani AP, Boselli L, Fernández Álvarez Á, Paloque L, Augereau JM, Gornitzka H, Benoit-Vical F.

Bioorg Med Chem. 2016 Jul 1;24(13):3075-3082. doi: 10.1016/j.bmc.2016.05.023. Epub 2016 May 17.

PMID:
27240469
9.

Plasmodium falciparum: multifaceted resistance to artemisinins.

Paloque L, Ramadani AP, Mercereau-Puijalon O, Augereau JM, Benoit-Vical F.

Malar J. 2016 Mar 9;15:149. doi: 10.1186/s12936-016-1206-9. Review.

10.

[Plasmodium falciparum resistance to artemisinin-based combination therapies (ACTs): Fears of widespread drug resistance].

Benoit-Vical F, Paloque L, Augereau JM.

Bull Acad Natl Med. 2016 Mar;200(3):477-89; discussion 490. Review. French.

PMID:
28644374
11.

In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.

Niaré K, Dara A, Sagara I, Sissoko MS, Guindo CO, Cissé NH, Coulibaly CO, Ringwald P, Benoit-Vical F, Berry A, Djimdé AA, Doumbo OK.

Am J Trop Med Hyg. 2016 Mar;94(3):634-9. doi: 10.4269/ajtmh.15-0503. Epub 2016 Jan 25.

12.

Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.

Ménard S, Ben Haddou T, Ramadani AP, Ariey F, Iriart X, Beghain J, Bouchier C, Witkowski B, Berry A, Mercereau-Puijalon O, Benoit-Vical F.

Emerg Infect Dis. 2015 Oct;21(10):1733-41. doi: 10.3201/eid2110.150682.

13.

Samvisterin, a new natural antiplasmodial betulin derivative from Uapaca paludosa (Euphorbiaceae).

Banzouzi JT, Soh PN, Ramos S, Toto P, Cavé A, Hemez J, Benoit-Vical F.

J Ethnopharmacol. 2015 Sep 15;173:100-4. doi: 10.1016/j.jep.2015.07.023. Epub 2015 Jul 17.

PMID:
26192809
14.

Evaluation of antiplasmodial and antileishmanial activities of herbal medicine Pseudelephantopus spiralis (Less.) Cronquist and isolated hirsutinolide-type sesquiterpenoids.

Girardi C, Fabre N, Paloque L, Ramadani AP, Benoit-Vical F, González-Aspajo G, Haddad M, Rengifo E, Jullian V.

J Ethnopharmacol. 2015 Jul 21;170:167-74. doi: 10.1016/j.jep.2015.05.014. Epub 2015 May 14.

PMID:
25980423
15.

SAYE: the story of an antimalarial phytomedicine from Burkina Faso.

Dakuyo Z, Meda AL, Ollo D, Kiendrebeogo M, Traoré-Coulibaly M, Novak J, Benoit-Vical F, Weisbord E, Willcox M.

J Altern Complement Med. 2015 Apr;21(4):187-95. doi: 10.1089/acm.2014.0147. Epub 2015 Mar 31. No abstract available.

PMID:
25826205
16.

Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.

Straimer J, Gnädig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst RM, Ménard D, Fidock DA.

Science. 2015 Jan 23;347(6220):428-31. doi: 10.1126/science.1260867. Epub 2014 Dec 11.

17.

Influence of amodiaquine on the antimalarial activity of ellagic acid: crystallographic and biological studies.

Żesławska E, Oleksyn B, Fabre A, Benoit-Vical F.

Chem Biol Drug Des. 2014 Dec;84(6):669-75. doi: 10.1111/cbdd.12359. Epub 2014 Jun 25.

PMID:
24890222
18.

Antiprotozoal activities of Millettia richardiana (Fabaceae) from Madagascar.

Rajemiarimiraho M, Banzouzi JT, Nicolau-Travers ML, Ramos S, Cheikh-Ali Z, Bories C, Rakotonandrasana OL, Rakotonandrasana S, Andrianary PA, Benoit-Vical F.

Molecules. 2014 Apr 3;19(4):4200-11. doi: 10.3390/molecules19044200.

19.

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D.

Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.

20.

Pyranocoumarin and triterpene from Millettia richardiana.

Rajemiarimiraho M, Banzouzi JT, Rakotonandrasana SR, Chalard P, Benoit-Vical F, Rasoanaivo LH, Raharisololalao A, Randrianjah R.

Nat Prod Commun. 2013 Aug;8(8):1099-100.

PMID:
24079177
21.

Both plants Sebastiania chamaelea from Niger and Chrozophora senegalensis from Senegal used in African traditional medicine in malaria treatment share a same active principle.

Garcia-Alvarez MC, Moussa I, Njomnang Soh P, Nongonierma R, Abdoulaye A, Nicolau-Travers ML, Fabre A, Wdzieczak-Bakala J, Ahond A, Poupat C, Ikhiri K, Benoit-Vical F.

J Ethnopharmacol. 2013 Oct 7;149(3):676-84. doi: 10.1016/j.jep.2013.07.024. Epub 2013 Jul 29.

PMID:
23906782
22.

Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug.

Robert A, Claparols C, Witkowski B, Benoit-Vical F.

Antimicrob Agents Chemother. 2013 Aug;57(8):3998-4000. doi: 10.1128/AAC.01064-13. Epub 2013 Jun 10.

23.

Synthesis, structures, and antimalarial activities of some silver(I), gold(I) and gold(III) complexes involving N-heterocyclic carbene ligands.

Hemmert C, Fabié A, Fabre A, Benoit-Vical F, Gornitzka H.

Eur J Med Chem. 2013 Feb;60:64-75. doi: 10.1016/j.ejmech.2012.11.038. Epub 2012 Dec 7.

PMID:
23287052
24.

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.

Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D.

Antimicrob Agents Chemother. 2013 Feb;57(2):914-23. doi: 10.1128/AAC.01868-12. Epub 2012 Dec 3.

25.

Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: the debate.

Dechy-Cabaret O, Benoit-Vical F.

J Med Chem. 2012 Dec 13;55(23):10328-44. doi: 10.1021/jm3005898. Epub 2012 Oct 17.

PMID:
23075290
26.

Implication of glutathione in the in vitro antiplasmodial mechanism of action of ellagic acid.

Njomnang Soh P, Witkowski B, Gales A, Huyghe E, Berry A, Pipy B, Benoit-Vical F.

PLoS One. 2012;7(9):e45906. doi: 10.1371/journal.pone.0045906. Epub 2012 Sep 28.

27.

Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.

Menard S, Morlais I, Tahar R, Sayang C, Mayengue PI, Iriart X, Benoit-Vical F, Lemen B, Magnaval JF, Awono-Ambene P, Basco LK, Berry A.

Malar J. 2012 Apr 12;11:113. doi: 10.1186/1475-2875-11-113.

28.

Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs.

Witkowski B, Lelièvre J, Nicolau-Travers ML, Iriart X, Njomnang Soh P, Bousejra-Elgarah F, Meunier B, Berry A, Benoit-Vical F.

PLoS One. 2012;7(3):e32620. doi: 10.1371/journal.pone.0032620. Epub 2012 Mar 5.

29.

Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.

Pascual A, Parola P, Benoit-Vical F, Simon F, Malvy D, Picot S, Delaunay P, Basset D, Maubon D, Faugère B, Ménard G, Bourgeois N, Oeuvray C, Didillon E, Rogier C, Pradines B.

Malar J. 2012 Feb 14;11:45. doi: 10.1186/1475-2875-11-45.

30.

Nrf2, a PPARγ alternative pathway to promote CD36 expression on inflammatory macrophages: implication for malaria.

Olagnier D, Lavergne RA, Meunier E, Lefèvre L, Dardenne C, Aubouy A, Benoit-Vical F, Ryffel B, Coste A, Berry A, Pipy B.

PLoS Pathog. 2011 Sep;7(9):e1002254. doi: 10.1371/journal.ppat.1002254. Epub 2011 Sep 15.

31.

Indole and aminoimidazole moieties appear as key structural units in antiplasmodial molecules.

Passemar C, Saléry M, Soh PN, Linas MD, Ahond A, Poupat C, Benoit-Vical F.

Phytomedicine. 2011 Oct 15;18(13):1118-25. doi: 10.1016/j.phymed.2011.03.010. Epub 2011 May 25.

PMID:
21612900
32.

Imported Plasmodium knowlesi malaria in a French tourist returning from Thailand.

Berry A, Iriart X, Wilhelm N, Valentin A, Cassaing S, Witkowski B, Benoit-Vical F, Menard S, Olagnier D, Fillaux J, Sire S, Le Coustumier A, Magnaval JF.

Am J Trop Med Hyg. 2011 Apr;84(4):535-8. doi: 10.4269/ajtmh.2011.10-0622.

33.

Do ethnobotanical and laboratory data predict clinical safety and efficacy of anti-malarial plants?

Willcox M, Benoit-Vical F, Fowler D, Bourdy G, Burford G, Giani S, Graziose R, Houghton P, Randrianarivelojosia M, Rasoanaivo P.

Malar J. 2011 Mar 15;10 Suppl 1:S7. doi: 10.1186/1475-2875-10-S1-S7. Review.

34.

pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies.

Witkowski B, Iriart X, Soh PN, Menard S, Alvarez M, Naneix-Laroche V, Marchou B, Magnaval JF, Benoit-Vical F, Berry A.

J Clin Microbiol. 2010 Oct;48(10):3797-9. doi: 10.1128/JCM.01057-10. Epub 2010 Jul 28.

35.

Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.

Witkowski B, Nicolau ML, Soh PN, Iriart X, Menard S, Alvarez M, Marchou B, Magnaval JF, Benoit-Vical F, Berry A.

Antimicrob Agents Chemother. 2010 Jul;54(7):3049-51. doi: 10.1128/AAC.00209-10. Epub 2010 Apr 19.

36.

Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism.

Witkowski B, Lelièvre J, Barragán MJ, Laurent V, Su XZ, Berry A, Benoit-Vical F.

Antimicrob Agents Chemother. 2010 May;54(5):1872-7. doi: 10.1128/AAC.01636-09. Epub 2010 Feb 16.

37.

Analgesic and anti-inflammatory effects of Cassia siamea Lam. stem bark extracts.

Nsonde Ntandou GF, Banzouzi JT, Mbatchi B, Elion-Itou RD, Etou-Ossibi AW, Ramos S, Benoit-Vical F, Abena AA, Ouamba JM.

J Ethnopharmacol. 2010 Jan 8;127(1):108-11. doi: 10.1016/j.jep.2009.09.040. Epub 2009 Sep 30.

PMID:
19799981
38.

Molecular method for the diagnosis of imported pediatric malaria.

Delhaes Jeanne L, Berry A, Dutoit E, Leclerc F, Beaudou J, Leteurtre S, Camus D, Benoit-Vical F.

Med Mal Infect. 2010 Feb;40(2):115-8. doi: 10.1016/j.medmal.2009.04.011. Epub 2009 Jul 23.

PMID:
19631483
39.

Resistance to antimalarial compounds: methods and applications.

Witkowski B, Berry A, Benoit-Vical F.

Drug Resist Updat. 2009 Feb-Apr;12(1-2):42-50. doi: 10.1016/j.drup.2009.01.001. Epub 2009 Mar 13. Review.

PMID:
19285915
40.

In vitro and in vivo properties of ellagic acid in malaria treatment.

Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez MC, Berry A, Benoit-Vical F.

Antimicrob Agents Chemother. 2009 Mar;53(3):1100-6. doi: 10.1128/AAC.01175-08. Epub 2008 Nov 17.

41.

Pfs 16 pivotal role in Plasmodium falciparum gametocytogenesis: a potential antiplasmodial drug target.

Berry A, Deymier C, Sertorio M, Witkowski B, Benoit-Vical F.

Exp Parasitol. 2009 Feb;121(2):189-92. doi: 10.1016/j.exppara.2008.10.010. Epub 2008 Nov 5.

PMID:
19014941
42.

[Hyperreactive malarial splenomegaly: three clinical cases and literature review].

Camara B, Kantambadouno JB, Martin-Blondel G, Berry A, Alvarez M, Benoit-Vical F, Delmont J, Bouchaud O, Marchou B.

Med Mal Infect. 2009 Jan;39(1):29-35. doi: 10.1016/j.medmal.2008.09.002. Epub 2008 Oct 25. French.

PMID:
18952389
43.

PCR-based methods to the diagnosis of imported malaria.

Berry A, Benoit-Vical F, Fabre R, Cassaing S, Magnaval JF.

Parasite. 2008 Sep;15(3):484-8. Review.

44.

Cogniauxia podolaena: bioassay-guided fractionation of defoliated stems, isolation of active compounds, antiplasmodial activity and cytotoxicity.

Banzouzi JT, Soh PN, Mbatchi B, Cavé A, Ramos S, Retailleau P, Rakotonandrasana O, Berry A, Benoit-Vical F.

Planta Med. 2008 Oct;74(12):1453-6. doi: 10.1055/s-2008-1081341. Epub 2008 Aug 14.

PMID:
18704883
45.

The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice.

Bousejra-El Garah F, Claparols C, Benoit-Vical F, Meunier B, Robert A.

Antimicrob Agents Chemother. 2008 Aug;52(8):2966-9. doi: 10.1128/AAC.00165-08. Epub 2008 Jun 16.

46.

Girolline: a potential lead structure for antiplasmodial drug research.

Benoit-Vical F, Saléry M, Soh PN, Ahond A, Poupat C.

Planta Med. 2008 Mar;74(4):438-44. doi: 10.1055/s-2008-1034348.

PMID:
18484539
47.

Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species.

Ribaut C, Berry A, Chevalley S, Reybier K, Morlais I, Parzy D, Nepveu F, Benoit-Vical F, Valentin A.

Malar J. 2008 Mar 5;7:45. doi: 10.1186/1475-2875-7-45.

48.

Evaluation of Senegalese plants used in malaria treatment: focus on Chrozophora senegalensis.

Benoit-Vical F, Soh PN, Saléry M, Harguem L, Poupat C, Nongonierma R.

J Ethnopharmacol. 2008 Feb 28;116(1):43-8. Epub 2007 Dec 11.

PMID:
18063330
49.

Modifications of the chemical structure of terpenes in antiplasmodial and antifungal drug research.

Olagnier D, Costes P, Berry A, Linas MD, Urrutigoity M, Dechy-Cabaret O, Benoit-Vical F.

Bioorg Med Chem Lett. 2007 Nov 15;17(22):6075-8. Epub 2007 Sep 18.

PMID:
17904365
50.

Are West African plants a source of future antimalarial drugs?

Soh PN, Benoit-Vical F.

J Ethnopharmacol. 2007 Nov 1;114(2):130-40. Epub 2007 Aug 17. Review.

PMID:
17884314

Supplemental Content

Loading ...
Support Center